Clinical Trials Browser

Phase 1/2 × Nasopharyngeal Neoplasms × 30 days × Clear all

NCT05261750 2026-02-25

Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer

Phase 1/2 Active not recruiting

Nasopharyngeal Neoplasms